Marksans Pharma Ltd declared that its UK subsidiary fully owned by them, Relonchem Limited, has obtained the marketing authorization from the UK Medicines and Healthcare Products Regulatory Agency
Shilpa Medicare Limited from instance, Raichur, Karnataka has been approved by the European Medicines Agency (EMA) to start selling its Rivaroxaban
Shree Ramkrishna Exports (SRK) Family, a worldwide leader in the natural diamond industry, are now in the healthcare sector through the starting of Kriam Pharma which is a project that concentrates on affordable medicines
Teva Pharmaceuticals, the U.S. branch of Teva Pharmaceutical Industries Ltd., shared the promising new long-term data of its schizophrenia drug portfolio at the 2025 Psych Congress Annual Meeting in San Diego, California.
Maxivision Super Speciality Eye Hospitals, one of India’s fastest-growing eye care chains, launches a first-of-its-kind initiative in Madhapur, Hyderabad to address the rapidly growing problem of myopia, furthering its mission to combat the...
First-of-its-kind digital health programme on Vidal Health’s platform will offer an end- to-end, convenient and cashless experience, making HPV vaccine more accessible Collaboration is part of Vidal Health’s efforts to provide preventive
The first comprehensive worldwide framework created to guarantee access to controlled drugs for medical and scientific uses while reducing the risks to public health that may arise from misuse and diversion was released by the World Health
Hetero Healthcare Ltd., one of the most prominent Indian pharmaceutical companies, in collaboration with Enzene Biosciences Ltd., has announced the introduction of Perzea, their cheapest biosimilar of Pertuzumab.
Biocon Biologics Ltd. (BBL), a world leader in biosimilars and part of Biocon Ltd., announced today an important achievement with the inclusion of Yesafili biosimilar on the Ontario Drug Benefit (ODB) Formulary/Comparative Drug Index...
Noida-based Jubilant Pharma Limited has shared the news that its wholly-owned subsidiary, Jubilant Pharma Limited, has wrapped up a Post-marketing Adverse Drug Experience
.jpg)
, CDSCO.jpg)